CAR T CELL THERAPY
Clinical trials for CAR T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can the RSV vaccine protect the most vulnerable? new study aims to find out
Disease control Not yet recruitingThis study tests whether the RSV vaccine Abrysvo can help blood cancer patients who have had a stem cell transplant or CAR-T therapy build immunity against RSV. Researchers will measure antibody levels before and after vaccination in 30 adults. The goal is to see if the vaccine t…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Engineered immune cells take aim at stubborn leukemia
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy (FO33 CAR-T) for people with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target a protein called CD33 found on mos…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New CAR-T shot could slash cancer treatment costs and time
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy that works inside the body, avoiding the complex and costly lab process usually needed. It targets two markers (CD19 and BAFF-R) on cancer cells in people with relapsed or hard-to-treat B-cell leukemia or lymphoma. The…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
New study aims to unravel brain inflammation after cancer treatment
Knowledge-focused Not yet recruitingThis study will observe 10 patients receiving CAR-T therapy to understand why some develop brain inflammation (ICANS). Researchers will use brain scans and cognitive tests to compare those with severe ICANS to those with mild or no symptoms. The goal is to learn more about the co…
Matched conditions: CAR T CELL THERAPY
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Jun 23, 2026 23:34 UTC
-
New study to compare patient Well-Being during two major blood cancer treatments
Knowledge-focused Not yet recruitingThis observational study will follow 162 patients with blood cancers like leukemia or lymphoma who are receiving either a stem cell transplant or CAR-T therapy. Researchers will use a simple questionnaire to track how symptoms and quality of life change from the start to the end …
Matched conditions: CAR T CELL THERAPY
Sponsor: Associazione Qol-one • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:56 UTC
-
Gene therapy patients monitored for 15 years in new safety study
Knowledge-focused Not yet recruitingThis study tracks 500 people who have received or will receive gene therapy products from Seattle Children's Therapeutics. The goal is to watch for any long-term side effects over up to 15 years. Participants will have regular check-ups and lab tests, but no new treatment is give…
Matched conditions: CAR T CELL THERAPY
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC